- $2.77bn
- $5.07bn
- $1.70bn
- 57
- 80
- 70
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,499 | 804 | 1,332 | 2,245 | 1,702 |
Cost of Revenue | |||||
Gross Profit | 1,097 | 466 | 986 | 1,842 | 1,312 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,285 | 1,191 | 995 | 1,580 | 1,227 |
Operating Profit | 215 | -387 | 337 | 665 | 474 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25.1 | -417 | -43.4 | 337 | 372 |
Provision for Income Taxes | |||||
Net Income After Taxes | -55.8 | -412 | -77.8 | 227 | 214 |
Net Income Before Extraordinary Items | |||||
Net Income | -55.8 | -412 | -77.8 | 227 | 214 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -55.8 | -412 | -77.8 | 227 | 214 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.09 | -0.622 | -0.143 | 1.04 | 0.727 |
Dividends per Share |